Medtronic (MDT) Cash & Current Investments (2014 - 2026)

Medtronic has disclosed Cash & Current Investments across 13 years of filings, most recently posting $8.8 billion for Q3 2026.

• In Q3 2026, Cash & Current Investments rose 8.6% year-over-year to $8.8 billion; the TTM figure through Jul 2026 stood at $8.8 billion (up 8.6% YoY), while the FY2026 annual figure was $9.2 billion, up 2.84% from the prior year.
• Cash & Current Investments came in at $8.8 billion for Q3 2026 at Medtronic, down from $9.2 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $11.4 billion in Q4 2022 to a low of $7.7 billion in Q4 2023.
• Average Cash & Current Investments over 5 years is $8.9 billion, with a median of $8.3 billion recorded in 2025.
• Year-over-year, Cash & Current Investments sank 32.34% in 2023 and grew 11.99% in 2025.
• Over 5 years, Cash & Current Investments stood at $11.4 billion in 2022, then slumped by 32.34% to $7.7 billion in 2023, then increased by 3.3% to $8.0 billion in 2024, then increased by 4.23% to $8.3 billion in 2025, then rose by 5.91% to $8.8 billion in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $8.8 billion in Q3 2026, $9.2 billion in Q2 2026, and $8.4 billion in Q1 2026.